Performance of Dexcom G5 and FreeStyle Libre sensors tested simultaneously in people with type 1 or 2 diabetes and advanced chronic kidney disease

Table 1 Baseline characteristics

Variable	All, n = 40	FAS population, n = 33
Age in yr	64.1 (9.2)	63.2 (9.2)
	66 (41; 77)	65.5 (41; 77)
	n = 39	n = 32
HbA1c in mmol/mol	53.1 (11.0)	53.9 (11.5)
	53 (31; 75)	54 (31; 75)
	n = 40	n = 33
HbA1c %	7 (3.2)	7.1 (3.2)
	53 (5; 9)	7.1 (5; 9)
	n = 40	n = 33
Dialysis
Not in dialysis	20 (50.0%)	17 (51.5%)
Hemodialysis	11 (27.5%)	7 (21.2%)
Peritoneal dialysis	9 (22.5%)	9 (27.3%)
Diabetes duration	28.5 (14.7)	29.2 (15.4)
	27.5 (5.3; 64.5)	28.5 (5.3; 64.5)
	n = 32	n = 26
Sex
Man	29 (74.4%)	22 (68.8%)
Woman	10 (25.6%)	10 (31.3%)
Smoking
No	25 (71.4%)	19 (67.9%)
Yes	3 (8.6%)	3 (10.7%)
Do not know	7 (20.0%)	6 (21.4%)
Systolic blood pressure in mmHg	145.6 (24.2)	146.5 (24.7)
	145 (95; 213)	142.5 (95; 213)
	n = 37	n = 30
Diastolic blood pressure in mmHg	77.4 (13.7)	78.6 (13.8)
	80 (52; 103)	80 (52; 103)
	n = 37	n = 30
Insulin delivery
Basal insulin only	12 (32.4%)	10 (33.3%)
Mix insulin	2 (5.4%)	2 (6.7%)
MDI	24 (64.9%)	20 (66.7%)
Other glucose lowering treatment	5 (13.5%)	3 (10.0%)
Total insulin dose per day	73.0 (60.3)	65.7 (63.8)
	45 (8; 277)	41 (8; 277)
	n = 25	n = 20
Type of diabetes
Type 1	11 (30.6%)	10 (33.3%)
Type 2	25 (69.4%)	20 (66.7%)

For categorical variables n (%) is presented. For continuous variables mean (SD)/median (min; max)/n = is presented. FAS: Full analysis set; MDI: Multiple daily injection.